What You Should Know: - Kelonia Therapeutics, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding to expand the benefit and reach of genetic medicines. - Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable therapeutic applications, and dose-limiting toxicities. By enabling precisely targeted, highly efficient, manufacturable “off-the-shelf” in
Read More
Cancer | Digital Health Impact on Cancer Care | Policy, News, Analysis, Insights - HIT Consultant
3 Steps to Approach & Tackle Digital Transformation in Healthcare
Artificial intelligence (AI) is predicted to save the US healthcare economy $150 billion by 2026. Replacing legacy systems and changing standard operating procedures, hospitals are moving to capitalize on technology and the ways it can change a historically hesitant to change sector. The big question is how fast teams are going to implement changes. Healthcare leadership recently reported that their organizations are 60% through their digitalization journey. IT leaders must be leading
Read More
Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions
What You Should Know: - Mayo Clinic has signed a research agreement with VUNO, a global medical artificial intelligence (AI) company to develop advanced AI-driven precision oncology solutions to deliver precision oncology care. - Through this research agreement, VUNO will establish a collaboration with Mayo Clinic to develop innovative AI and machine learning solutions for more precise diagnosis, prognosis and treatment stratification in cancer. - This collaborative agreement combines
Read More
Using NLP Technology To Uncover Real-World Patient Insights
It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years. As difficult as it is to ignore the massive impact that connected technologies and social media have had on the way we experience our world, it’s somehow even more challenging to fully grasp the scale of it. For health researchers, this data explosion – and especially the rise
Read More
Golden Valley Memorial Goes Live on MEDITECH Expanse Genomics
What You Should Know: - MEDITECH announces that Golden Valley Memorial Healthcare (GVMH) is their first client to go live on Expanse Genomics, opening the organization’s possibilities for delivering precision medicine by allowing them to analyze and parse genetic results into discrete, actionable data, displayed directly in patient charts. - Providers can order genetic testing directly in Expanse, and the results will be received and stored in a codified format along with full PDF reports
Read More
Transcarent Launches Oncology Care for Collaborative Cancer Care Experience
What You Should Know: - Transcarent, a new, different, and better health and care experience company for employees of self-insured employers and their families launches Transcarent Oncology Care, a collaborative cancer care experience that connects employees and their families with high-quality cancer care from leading cancer institutes, top-rated oncology providers and researchers, and clinical trial identification irrespective of their geographic location. - Transcarent Oncology Care
Read More
NCODA & XIFIN Launch Initiative to Expand Oncology Patient Care Options
What You Should Know: - XIFIN has partnered with NCODA, Inc., a globally recognized association that develops unique resources to help medically integrated oncology teams deliver top-tier care. This new strategic partnership “NCODA Informatics Initiative Powered by VisualStrata” provides the use of VisualStrata as part of the NCODA membership. - As oncology groups work to find and secure clinical trials – thereby expanding patient care options within their practice – purpose-built
Read More
PathAI and GlaxoSmithKline Partner to Accelerate Research and Drug Development
What You Should Know: - PathAI and GSK announced a multi-year strategic artificial intelligence (AI) partnership today with a focus on accelerating research and- building drug development programs in oncology and non-alcoholic steatohepatitis (NASH). - As part of the partnership, GSK will leverage both PathAI’s expertise and models to advance GSK’s proprietary AI models and focus on designing better models to deliver improved treatment options for patients with cancer
Read More
C2i Genomics Brings Distributed Cancer Monitoring to Cancer Centers Across Europe
What You Should Know: - C2i Genomics, a cancer intelligence company launches its C2inform minimal residual disease (MRD) test across Europe, after obtaining CE-IVD marking in the EU, UK and Switzerland. The company also announced the completion of several clinical trials across the globe, including leading cancer centers in Europe, U.S. and Singapore. - The new clinical data will be presented at the 2022 American Association for Cancer Research (AACR) annual meeting in New Orleans,
Read More
Blue Shield of CA & Walgreens Launch Health Advisory Services in Retail Stores
What You Should Know: - Blue Shield of CA and Walgreens Health announces a new health advisory service that will expand access to care management and coordination for Californians through in-store and virtual resources through the launch of 12 new Walgreens Health Corner™ locations in the San Francisco Bay Area and Los Angeles County. - With the addition of Walgreens Health Corner™ locations in LA and the
Read More
